Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.30 |
| ▸ | FNTB | P49356 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5372700 | 1.00 | KDM4E (0.47) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL1775718 | 0.96 | — | — | |
| SCHEMBL57052 | 0.96 | — | — | |
| SCHEMBL1830619 | 0.96 | — | — | |
| SCHEMBL3263169 | 0.93 | — | — | |
| SCHEMBL218863 | 0.80 | FOLH1 (0.39) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL5729609 | 0.80 | FOLH1 (0.39) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL6398091 | 0.80 | KDM4E (0.42) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Acetylcysteine SCHEMBL663702 | 0.75 | MAPT (0.84) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL7447971 | 0.74 | ACE (0.47) | KDM4EMAPTTHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090311292-A1 | PROCESS FOR SYNTHESIS AND INCORPORATION OF NITRIC OXIDE DONORS IN MACROMOLECULAR COMPOSITIONS | CRISTALIA PRODUTOS QUIMICOS FARMACEUTICOS LTDA. (BR) | 2009-12-17 | — | — | US | disclosed |
| WO-2008031182-A1 | PROCESS FOR SYNTHESIS AND INCORPORATION OF NITRIC OXIDE DONORS IN MACROMOLECULAR COMPOSITIONS | Cristália Produtos Químicos Farmacêuticos Ltda. (BR) | 2008-03-20 | — | — | WO | disclosed |
| EP-1251838-A2 | METHOD FOR USING POTASSIUM CHANNEL AGONISTS FOR DELIVERING A MEDICANT TO AN ABNORMAL BRAIN REGION AND/OR A MALIGNANT TUMOR | Cedars-Sinai Medical Center (US) | 2002-10-30 | — | — | EP | disclosed |
| EP-1251840-A2 | METHOD FOR USING POTASSIUM CHANNEL ACTIVATION FOR DELIVERING A MEDICANT TO AN ABNORMAL BRAIN REGION AND/OR A MALIGNANT TUMOR | CEDARS-SINAI MEDICAL CENTER (US) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001054680-A2 | METHOD FOR USING POTASSIUM CHANNEL ACTIVATION FOR DELIVERING A MEDICANT TO AN ABNORMAL BRAIN REGION AND/OR A MALIGNANT TUMOR | CEDARS-SINAI MEDICAL CENTER (US) | 2001-08-02 | — | — | WO | disclosed |
| WO-2001054771-A2 | METHOD FOR USING POTASSIUM CHANNEL AGONISTS FOR DELIVERING A MEDICANT TO AN ABNORMAL BRAIN REGION AND/OR A MALIGNANT TUMOR | CEDARS-SINAI MEDICAL CENTER (US) | 2001-08-02 | — | — | WO | disclosed |